A phase 2b Study of Merimepodib in Combination with Pegylated Interferon Alfa 2a-(Pegasys) and Ribvarin in Subjects with Chronic Genotype 1 Hepat

  • Koch, Alvaro (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/27/044/30/07